Sinopharm Suits Zimbabwe’s Cold Chain Capacity

UNLIKE other COVID-19 vaccines that were developed using  the Messenger Ribonucleic Acids (M-RNA) technology, vaccines manufactured using a killed/inactivated virus such as the Sinopharm, Sinovac and COVAXIN currently being administered in Zimbabwe do not require expensive subzero cold-chain infrastructure. By Michael Gwarisa The messenger RNA technology was deployed in the Pfizer, Mordena and other vaccines, making such vaccines unsuitable for hot climatic conditions such as the one in Zimbabwean unless the country installs a costly deep freeze airport warehouse, procures and modifies refrigerated vehicles and inoculation points to ensure the…

Read More

Zim COVID-19 Epidemic Curve Flattening – Dr Grant

Dr Grant Murewanhema

LOCAL Public Health Expert and Epidemiologist, Dr Grant Murewanhema has hinted that Zimbabwe’s epidemic curve was at the verge of flattening even though clustered sections of infections were still reported at community level. By Michael Gwarisa An epidemic curve, also known as an epi curve or epidemiological curve, is a statistical chart used to visualize the onset and progression of a disease outbreak. Presenting during an editors workshop that was organized by the National AIDS Council, Dr Grant said there was need to scale-up COVID-19 prevention interventions in  a bid…

Read More